Avecho Biotechnology Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.026x

Avecho Biotechnology Ltd cash flow conversion efficiency. Based on the latest financial reports, Avecho Biotechnology Ltd (AVE) has a cash flow conversion efficiency ratio of -0.026x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-49.47K ≈ $-35.00K USD) by net assets (AU$1.91 Million ≈ $1.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Avecho Biotechnology Ltd (1993–2025)

Cash flow conversion efficiency of Avecho Biotechnology Ltd from 1993 to 2025. This chart illustrates how Avecho Biotechnology Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View AVE stock price and chart for real-time trading data and today's change.

Avecho Biotechnology Ltd Cash Flow Conversion Ratio Explained

Avecho Biotechnology Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Avecho Biotechnology Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avecho Biotechnology Ltd ranked by their cash flow conversion efficiency. Also see how much is Avecho Biotechnology Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Kinatico Ltd AU:KYP	0.084x
Success Transformer Corporation Bhd KLSE:7207	0.015x
Dancomech Holdings Bhd KLSE:5276	0.019x
Jack Chia Industries (Thailand) Public Company Limited BK:JCT	0.021x
VBARE Iberian Properties SOCIMI SA MC:YVBA	-0.005x
TPC Consolidated Ltd AU:TPC	-0.057x
Innometry Co. Ltd KQ:302430	0.019x
Carbon Streaming Corp NEO:NETZ	0.003x

Annual Cash Flow Conversion Efficiency for Avecho Biotechnology Ltd (1993–2025)

The table below shows the annual cash flow conversion efficiency of Avecho Biotechnology Ltd from 1993 to 2025. Review Avecho Biotechnology Ltd (AVE) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$1.56 Million ≈ $1.10 Million	AU$1.10 Million ≈ $780.51K	0.707x	+158.27%
2024-12-31	AU$3.27 Million ≈ $2.31 Million	AU$-3.97 Million ≈ $-2.81 Million	-1.214x	-143.44%
2023-12-31	AU$6.38 Million ≈ $4.51 Million	AU$-3.18 Million ≈ $-2.25 Million	-0.499x	+27.39%
2022-12-31	AU$2.42 Million ≈ $1.72 Million	AU$-1.67 Million ≈ $-1.18 Million	-0.687x	-0.54%
2021-12-31	AU$4.54 Million ≈ $3.21 Million	AU$-3.10 Million ≈ $-2.19 Million	-0.683x	-27.40%
2020-12-31	AU$2.65 Million ≈ $1.88 Million	AU$-1.42 Million ≈ $-1.01 Million	-0.536x	-314.63%
2019-12-31	AU$4.76 Million ≈ $3.37 Million	AU$1.19 Million ≈ $841.16K	0.250x	+144.53%
2018-12-31	AU$3.90 Million ≈ $2.76 Million	AU$-2.19 Million ≈ $-1.55 Million	-0.561x	+44.06%
2017-12-31	AU$6.40 Million ≈ $4.53 Million	AU$-6.42 Million ≈ $-4.54 Million	-1.003x	-82.12%
2016-12-31	AU$11.65 Million ≈ $8.24 Million	AU$-6.41 Million ≈ $-4.54 Million	-0.551x	-82.97%
2015-12-31	AU$28.93 Million ≈ $20.47 Million	AU$-8.71 Million ≈ $-6.16 Million	-0.301x	-118.93%
2014-12-31	AU$49.03 Million ≈ $34.69 Million	AU$-6.74 Million ≈ $-4.77 Million	-0.137x	+34.67%
2013-12-31	AU$40.77 Million ≈ $28.85 Million	AU$-8.58 Million ≈ $-6.07 Million	-0.210x	-12.95%
2012-12-31	AU$62.61 Million ≈ $44.30 Million	AU$-11.66 Million ≈ $-8.25 Million	-0.186x	-46.22%
2011-12-31	AU$72.95 Million ≈ $51.61 Million	AU$-9.29 Million ≈ $-6.58 Million	-0.127x	+40.42%
2010-12-31	AU$39.01 Million ≈ $27.60 Million	AU$-8.34 Million ≈ $-5.90 Million	-0.214x	-19.25%
2009-12-31	AU$49.99 Million ≈ $35.37 Million	AU$-8.96 Million ≈ $-6.34 Million	-0.179x	-27.81%
2008-12-31	AU$51.55 Million ≈ $36.48 Million	AU$-7.23 Million ≈ $-5.12 Million	-0.140x	-72.82%
2007-12-31	AU$133.76 Million ≈ $94.65 Million	AU$-10.86 Million ≈ $-7.68 Million	-0.081x	-35.51%
2006-12-31	AU$135.47 Million ≈ $95.86 Million	AU$-8.12 Million ≈ $-5.74 Million	-0.060x	-73.92%
2005-12-31	AU$132.14 Million ≈ $93.50 Million	AU$-4.55 Million ≈ $-3.22 Million	-0.034x	-187.04%
2004-12-31	AU$113.22 Million ≈ $80.11 Million	AU$-1.36 Million ≈ $-961.27K	-0.012x	+57.60%
2003-12-31	AU$29.38 Million ≈ $20.79 Million	AU$-831.60K ≈ $-588.41K	-0.028x	+53.36%
2002-12-31	AU$14.81 Million ≈ $10.48 Million	AU$-898.56K ≈ $-635.79K	-0.061x	-18.47%
2001-12-31	AU$18.34 Million ≈ $12.98 Million	AU$-939.40K ≈ $-664.68K	-0.051x	-29.20%
2000-12-31	AU$20.67 Million ≈ $14.63 Million	AU$-819.60K ≈ $-579.92K	-0.040x	+41.04%
1999-12-31	AU$5.02 Million ≈ $3.55 Million	AU$-337.79K ≈ $-239.01K	-0.067x	+73.74%
1998-12-31	AU$1.59 Million ≈ $1.12 Million	AU$-406.45K ≈ $-287.59K	-0.256x	+63.11%
1997-12-31	AU$5.45 Million ≈ $3.86 Million	AU$-3.78 Million ≈ $-2.68 Million	-0.694x	-540.59%
1996-12-31	AU$27.18 Million ≈ $19.23 Million	AU$-2.94 Million ≈ $-2.08 Million	-0.108x	-118.58%
1995-12-31	AU$28.90 Million ≈ $20.45 Million	AU$-1.43 Million ≈ $-1.01 Million	-0.050x	+56.02%
1994-12-31	AU$10.81 Million ≈ $7.65 Million	AU$-1.22 Million ≈ $-862.52K	-0.113x	-5205.41%
1993-12-31	AU$10.42 Million ≈ $7.37 Million	AU$23.00K ≈ $16.27K	0.002x	--

About Avecho Biotechnology Ltd

AU:AVE Australia Biotechnology

Market Cap

$35.54 Million

AU$50.23 Million AUD

Market Cap Rank

#22952 Global

#830 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.03

All Time High

AU$0.04